THOMAS, Astrid Maria
 Distribuzione geografica
Continente #
NA - Nord America 13.529
EU - Europa 9.694
AS - Asia 7.926
SA - Sud America 1.049
Continente sconosciuto - Info sul continente non disponibili 678
AF - Africa 111
OC - Oceania 21
Totale 33.008
Nazione #
US - Stati Uniti d'America 13.238
SG - Singapore 3.004
CN - Cina 2.347
IT - Italia 1.914
RU - Federazione Russa 1.579
UA - Ucraina 1.375
IE - Irlanda 1.139
GB - Regno Unito 1.002
TR - Turchia 884
BR - Brasile 831
SE - Svezia 708
FR - Francia 694
VN - Vietnam 675
DE - Germania 562
IN - India 370
FI - Finlandia 321
BD - Bangladesh 184
CA - Canada 154
HK - Hong Kong 111
AR - Argentina 77
NL - Olanda 74
MX - Messico 70
JP - Giappone 64
PL - Polonia 59
ES - Italia 47
IQ - Iraq 39
AT - Austria 34
ZA - Sudafrica 34
CZ - Repubblica Ceca 33
CO - Colombia 32
EC - Ecuador 32
ID - Indonesia 29
LU - Lussemburgo 25
PK - Pakistan 25
BE - Belgio 23
IR - Iran 23
KR - Corea 23
CH - Svizzera 21
EU - Europa 20
MA - Marocco 19
VE - Venezuela 19
CL - Cile 18
UZ - Uzbekistan 18
SA - Arabia Saudita 15
EG - Egitto 14
JM - Giamaica 14
MY - Malesia 14
PE - Perù 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
HN - Honduras 13
IL - Israele 13
LT - Lituania 13
PH - Filippine 12
RO - Romania 12
KE - Kenya 11
CR - Costa Rica 10
PT - Portogallo 10
UY - Uruguay 10
DK - Danimarca 9
GR - Grecia 9
JO - Giordania 9
EE - Estonia 7
NZ - Nuova Zelanda 7
SN - Senegal 7
TN - Tunisia 7
AZ - Azerbaigian 6
GT - Guatemala 6
LB - Libano 6
PY - Paraguay 6
AO - Angola 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
DZ - Algeria 4
ET - Etiopia 4
GY - Guiana 4
HU - Ungheria 4
NP - Nepal 4
SI - Slovenia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
SM - San Marino 3
AM - Armenia 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
OM - Oman 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AW - Aruba 1
BG - Bulgaria 1
Totale 32.322
Città #
Singapore 2.169
San Jose 1.715
Jacksonville 1.496
Chandler 1.333
Dublin 1.121
Ashburn 755
Southend 690
Council Bluffs 660
Princeton 567
Dallas 519
Beijing 500
Izmir 454
Nanjing 444
Los Angeles 357
Wilmington 299
Dearborn 260
Cambridge 241
Santa Clara 240
Ho Chi Minh City 221
Buffalo 195
Tongling 183
New York 164
Altamura 162
The Dalles 162
Nanchang 148
Hanoi 141
Chieti 128
Munich 116
Ann Arbor 115
Rome 109
Woodbridge 109
Moscow 101
Hong Kong 96
Milan 94
Boardman 93
São Paulo 91
Shenyang 84
Hebei 76
Orem 72
Redondo Beach 71
Tianjin 71
Houston 70
Jiaxing 61
Pescara 57
Toronto 54
Grevenbroich 53
Atlanta 52
Hefei 52
Helsinki 51
Washington 50
Kunming 49
London 45
Tokyo 44
Norwalk 43
Brooklyn 42
Warsaw 41
Montreal 40
Chennai 39
Denver 39
Hangzhou 38
Changsha 37
Phoenix 37
Columbus 36
Chicago 35
Jinan 34
Silver Spring 32
Da Nang 30
Kimball 30
Frankfurt am Main 29
San Francisco 29
Stockholm 29
Turku 29
Florence 28
Lanzhou 28
Naples 28
Haiphong 27
Manchester 27
Rio de Janeiro 25
Belo Horizonte 24
Mexico City 23
Poplar 23
Augusta 21
Biên Hòa 21
Dong Ket 21
Johannesburg 21
Mount Pleasant 20
Seoul 20
Boston 19
Changchun 19
Orange 19
Ardabil 18
Charlotte 18
Falls Church 18
Ningbo 18
Taizhou 18
Amsterdam 17
Nuremberg 17
Paris 17
Tashkent 17
Baghdad 16
Totale 18.517
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.232
Emergenza neurologica - tempesta distonica: diagnosi e terapia 504
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 317
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 291
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 210
Pre-trattamento antiematico per Test/terapia all'apomorfina 203
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 201
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 198
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 184
Akinetic crisis in Dementia with Lewy Bodies 178
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 174
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 173
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 172
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 170
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 169
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 167
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 166
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 164
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 163
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 163
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 163
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 162
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis 161
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 161
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 160
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 159
Functional specialization in human visual cortex: Evaluation by visual evoked potentials and fMRI 158
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 158
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 158
Improving diagnostic accuracy of DLB: An MRI study 158
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 157
Progetto atrofia multisistemica: risultati preliminari. 155
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 153
Bipallidal lesions induce delayed and progressive parkinsonism 153
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 153
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 151
A stage-based approach to therapy in parkinson’s disease 150
Autoscopic phenomena: case report and review of literature. 148
Attention network in AD and DLB patients: a resting fMRI study. 148
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 147
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 145
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 143
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 143
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 143
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 142
Acute akinesia or akinetic crisis in Parkinson's disease. 141
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 140
Acute akinesia in Parkinson disease. 139
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 138
P3 topography in brain lesions 136
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 136
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 136
3D localization of interictal epileptic activity by neuromagnetic method 135
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 135
Heat shock protein 70: implication for Alzheimer's disease 135
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 135
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 135
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 135
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 134
Atrofia Multisistemica: approccio diagnostico multidisciplinare 134
Catamenial end-off dose in Parkinson's disease 134
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 133
Pathological Gambling in PD is reduced by Amantadine 133
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 133
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 133
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 132
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 131
Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings. 131
Neurite ottica: relazione tra perimetria, PEV e RMN 130
Altitudinal visual stimuli and the cruciform model of evoked potentials. 130
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 130
Mitochondrial Involvement in Neurodegenerative Dementia 130
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 130
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 129
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 128
Somatization in Parkinson's Disease: A systematic review 128
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 127
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 127
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 126
Acetyl-L-carnitine:from a biological curiosity to a drug for the peripheral nervous system and beyond. 126
EEG IN PARKINSON'S DISEASE WITH DEMENTIA PREDICTS THE APPEARANCE OF FLUCTUATING COGNITION. XL Congresso SIN, Padova, novembre 2009. 125
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 125
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 125
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 125
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 124
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 124
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 124
Cohort study on tremor in DLB: prevalence and features 123
Post traumatic stress disorder heralding the onset of semantic frontotemporal dementia 123
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 122
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 121
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 121
Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies. 121
Using global team science to identify genetic parkinson's disease worldwide 121
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 120
Are P300 asymmetries in focal brain lesions reference dependent? 120
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 120
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 120
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 120
Paradoxical kinesia in parkinsonian patients surviving earthquake. 120
Totale 16.117
Categoria #
all - tutte 126.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.003 0 0 0 129 60 31 26 95 71 46 175 370
2022/20233.715 301 430 246 390 366 759 240 244 492 55 89 103
2023/20241.714 133 75 124 85 92 432 429 52 37 63 29 163
2024/20254.251 266 717 618 126 103 156 100 241 340 260 437 887
2025/202610.353 840 336 992 1.226 799 630 1.525 621 1.608 801 680 295
2026/20271.793 228 473 424 668 0 0 0 0 0 0 0 0
Totale 33.008